Steven Sparagana
- Physiology top 1%
- Tuberous Sclerosis Complex Research 31
- Histiocytic Disorders and Treatments 9
- Oncology top 5%
- Polyomavirus and related diseases 8
- Genetics top 5%
-
- Neurobiology and Insect Physiology Research 4
-
- Intraoperative Neuromonitoring and Anesthetic Effects 8
- Spinal Fractures and Fixation Techniques 3
-
- Cannabis and Cannabinoid Research 5
-
- Metabolism and Genetic Disorders 3
- Co-authors
- E. Steve RoachMauricio R. DelgadoDavid H. EwaltE. Martina BebinEugene G. SheffieldDavid Neal FranzЕ. Д. БелоусоваMichael Frost
- Cited by
- PhysiologyOncologyGenetics
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Steven Sparagana
60 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Physiology 1.8k
- Oncology 691
- Genetics 466
- Pulmonary and Respiratory Medicine 525
- Cellular and Molecular Neuroscience 286
Countries citing papers authored by Steven Sparagana
This map shows the geographic impact of Steven Sparagana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Sparagana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Sparagana more than expected).
Fields of papers citing papers by Steven Sparagana
This network shows the impact of papers produced by Steven Sparagana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Sparagana. The network helps show where Steven Sparagana may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steven Sparagana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 56 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 6 | |
| 4 | 2019 | 69 | |
| 5 | 2017 | 5 | |
| 6 | 2017 | 28 | |
| 7 | 2017 | 11 | |
| 8 | 2014 | 1 | |
| 9 | 2014 | 127 | |
| 10 | 2014 | 8 | |
| 11 | 2014 | 62 | |
| 12 | 2013 | 4 | |
| 13 | Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialbreakdown → | 2012 | 578 |
| 14 | 2011 | 34 | |
| 15 | 2010 | 8 | |
| 16 | 2007 | 296 | |
| 17 | 2003 | 45 | |
| 18 | Brief Communication : Felbamate Urolithiasis | 2001 | 14 |
| 19 | 2001 | 18 | |
| 20 | 2000 | 149 |
About Steven Sparagana
Steven Sparagana is a scholar working on Physiology, Cellular and Molecular Neuroscience and Clinical Biochemistry, having authored 60 papers that have together received 2.8k indexed citations. Recurring topics across this work include Tuberous Sclerosis Complex Research (31 papers), Histiocytic Disorders and Treatments (9 papers), Polyomavirus and related diseases (8 papers), Intraoperative Neuromonitoring and Anesthetic Effects (8 papers), Cannabis and Cannabinoid Research (5 papers), Neurobiology and Insect Physiology Research (4 papers), Spinal Fractures and Fixation Techniques (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Physiology (1.8k citations), Oncology (691 citations) and Genetics (466 citations). Steven Sparagana has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include E. Steve Roach, Mauricio R. Delgado, David H. Ewalt, E. Martina Bebin, Eugene G. Sheffield, David Neal Franz, Е. Д. Белоусова, Michael Frost, Michael Kohrman and Joyce Y. Wu. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.